Developers, not doctors, should be held accountable for generative AI medical devices, providers say
Health AdministrationLawMedicine
THE AI ANGLE
Powering medical devices that generate information and clinical adviceMajor healthcare associations asked the FDA to hold developers responsible for the safety and performance of generative AI medical devices. Providers stated that monitoring opaque algorithms places an unfair operational and malpractice burden on clinical practices. The upcoming FDA guidance could determine how liability and monitoring duties are divided between manufacturers and healthcare staff.
THE TEACHING ANGLE
Assigning liability between software creators and healthcare providers tests whether clinician supervision remains a practical legal defense when AI systems fail.Read the original at healthcaredive.com Generate teaching or study materials
More in Health Administration
- There are risks when children use AI chatbots. Does Australia's new 'digital duty of care' address them?Phys.org — Technology · October 27, 2026
- A Market, Not a Mandate, Is the Fastest Way to Bring AI Into HospitalsMedCity News · October 27, 2026
- AI's preference for drugs with a strong online presence may cost millionsMedical Xpress · October 27, 2026
- New Records Obtained by EFF Expose More Problems with Medicare’s AI ExperimentEFF Deeplinks · October 27, 2026
- Fortune 500 Healthcare Company Asks For AI To Negotiate Contracts With No Human LawyersAbove the Law · October 27, 2026